Traphagen Investment Advisors’s Ulta Beauty ULTA Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-580
Closed -$351K 213
2025
Q4
$351K Sell
580
-21
-3% -$11.5K 0.03% 143
2025
Q3
$329K Buy
601
+51
+9% +$26.1K 0.03% 147
2025
Q2
$257K Hold
550
0.02% 159
2025
Q1
$202K Hold
550
0.02% 174
2024
Q4
$239K Hold
550
0.02% 158
2024
Q3
$214K Hold
550
0.02% 162
2024
Q2
$212K Hold
550
0.02% 158
2024
Q1
$288K Hold
550
0.03% 136
2023
Q4
$269K Sell
550
-5
-0.9% -$2.11K 0.03% 136
2023
Q3
$222K Buy
555
+5
+0.9% +$2.19K 0.03% 144
2023
Q2
$259K Sell
550
-50
-8% -$24.5K 0.03% 133
2023
Q1
$327K Sell
600
-5
-0.8% -$2.57K 0.05% 115
2022
Q4
$284K Buy
605
+5
+0.8% +$2.16K 0.04% 123
2022
Q3
$241K Hold
600
0.04% 117
2022
Q2
$231K Hold
600
0.04% 123
2022
Q1
$239K Hold
600
0.04% 124
2021
Q4
$247K Hold
600
0.04% 122
2021
Q3
$217K Sell
600
-5,505
-90% -$1.99M 0.04% 123
2021
Q2
$357K Buy
+6,105
New +$2M 0.06% 99
2019
Q3
Sell
-600
Closed -$208K 117
2019
Q2
$208K Hold
600
0.06% 104
2019
Q1
$209K Buy
+600
New +$181K 0.06% 98

Other funds holding ULTA

Traphagen Investment Advisors's ULTA Position: Q1 2026 in Review

Traphagen Investment Advisors sold out of Ulta Beauty (ULTA) in Q1 2026, closing a stake of 580 shares — an estimated $351K sold.

Traphagen Investment Advisors first reported a position in ULTA in Q1 2019 and held it in 21 quarters. The position peaked at $357K in Q2 2021. 1,090 funds tracked by Wall St. Rank hold ULTA as of Q1 2026.

  • Traphagen Investment Advisors reported no remaining Ulta Beauty position as of Q1 2026 after selling out during the quarter.
  • Traphagen Investment Advisors sold 580 Ulta Beauty shares in Q1 2026, an estimated $351K.
  • Traphagen Investment Advisors first reported a position in Ulta Beauty in Q1 2019 and held it in 21 quarters.
  • Traphagen Investment Advisors's Ulta Beauty position peaked at $357K in Q2 2021.
  • 1,090 funds tracked by Wall St. Rank held Ulta Beauty as of Q1 2026.

Based on Traphagen Investment Advisors's 13F filing for Q1 2026, filed 22 Apr 2026.